NDRA Logo

ENDRA Life Sciences Inc. (NDRA) 

NASDAQ
Market Cap
$2.88M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
414 of 960
Rank in Industry
19 of 52

Largest Insider Buys in Sector

NDRA Stock Price History Chart

NDRA Stock Performance

About ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound …

Insider Activity of ENDRA Life Sciences Inc.

Over the last 12 months, insiders at ENDRA Life Sciences Inc. have bought $0 and sold $0 worth of ENDRA Life Sciences Inc. stock.

On average, over the past 5 years, insiders at ENDRA Life Sciences Inc. have bought $58,075 and sold $173,942 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 0 shares for transaction amount of $0 was made by UBS Group AG (Market maker/broker‑dealer) on 2024‑08‑27.

List of Insider Buy and Sell Transactions, ENDRA Life Sciences Inc.

2024-08-27PurchaseMarket maker/broker-dealer
0
$0$0-59.54%
2023-05-18PurchaseChief Technology Officer
15,000
0.8073%
$1.65$24,750-21.68%
2023-05-02Purchasedirector
83,333
3.2618%
$1.20$100,000-32.94%
2022-12-09PurchaseChief Technology Officer
1,500
0.1664%
$3.40$5,100-56.85%
2022-11-23Purchasedirector
10,000
0.0555%
$0.17$1,700-54.13%
2022-08-22PurchaseChief Technology Officer
20,000
0.1761%
$0.27$5,400-32.08%
2022-08-22Purchase
20,000
0.1696%
$0.26$5,200-32.08%
2022-05-26PurchaseChief Technology Officer
25,000
0.1712%
$0.21$5,250-6.22%
2022-05-18PurchaseChief Technology Officer
25,000
0.1794%
$0.22$5,500-1.74%
2022-05-17PurchaseChief Executive Officer
5,100
0.0316%
$0.19$969+18.62%
2022-05-16Purchase
100,000
0.6403%
$0.20$19,630+15.61%
2021-08-26Saledirector
5,000
0.3017%
$1.85$9,250-78.92%
2021-08-25Saledirector
45,000
2.6861%
$1.83$82,350-76.76%
2021-04-07SaleChief Technology Officer
15,000
1.2379%
$2.53$37,950-35.26%
2021-03-29SaleChief Technology Officer
18,750
1.4495%
$2.37$44,438-28.33%
2021-01-13SaleChief Commercial Officer
13,696
0.4914%
$1.10$15,066+87.50%
2021-01-12SaleChief Commercial Officer
6,304
0.2159%
$1.05$6,619+85.71%
2021-01-08Saledirector
10,000
0.2936%
$0.90$9,000+111.96%
2021-01-08SaleChief Commercial Officer
8,731
0.2677%
$0.94$8,207+111.96%
2021-01-06SaleChief Financial Officer
34,900
1.0245%
$0.90$31,410+131.95%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.